trending Market Intelligence /marketintelligence/en/news-insights/trending/Rx24CqUaRqd7kWMeUeMNhw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

S&P cuts Endo International's corporate credit rating to B from B+

Blog

JMP Securities is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition


S&P cuts Endo International's corporate credit rating to B from B+

S&P Global Ratings downgraded Endo International plc's corporate credit rating to B from B+.

The outlook on the ratings is stable.

According to the rating agency, Endo's businesses are being negatively affected by continued generic pricing pressures and increased scrutiny on opioid prescriptions. The rating on Endo is also supported by the increased scale from the Par acquisition, product diversification and research and development capabilities in the competitive generic pharmaceutical market.

S&P said the stable outlook reflects expected lower revenue and EBITDA over the next year due to continued price erosion, lower market shares and asset divestitures.

S&P Global Ratings and S&P Global Market Intelligence are owned by S&P Global Inc.